Alphabetical listing of all products

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Prices
  • 5 mg - 103 EUR
  • 25 mg - 412 EUR
  • 100 mg - 1236 EUR

Bortezomib

Bortezomib is a synthetic dipeptide boronic acid that acts a potent (Ki = 0.6 nM) and selective inhibitor of 26S proteasome activity. It has been approved as a drug for newly diagnosed multiple myeloma patients and for relapsed/refractory multiple myeloma and mantle cell lymphoma, for which it has become a treatment of choice.

catalogue number: B019
synonyms: Velcade, PS-341
CAS: 179324-69-7
MW: 384.24 g/mol

References
Clin Cancer Res. 1999 Sep;5(9):2638-45. PMID: 10499643
Curr Cancer Drug Targets. 2011 Mar;11(3):239-53. PMID: 21247388